Gilead Lures Roche Pharma CEO O'Day As CEO; Genentech's CEO Will Replace Him

 
• By Sten Stovall
  
Daniel O Day
O'Day Seen Bringing Valuable M&A, Oncology Experience To Gilead
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Executives On The Move

More from Leadership